Home

Pharma China Web Edition

Pharma China Archives

Online Databases

Subscription/Order/Info

Event Calendar

China Pharma Providers

About Us

	News     The Market     Industry News     Regulatory News     General Health     Legal/IPR News     Product/R&D News     API/Bulk Drug News     People in the News     Other News     Top News Worldwide Feature articles     Editorials     Commentaries     Expert Opinions     Interviews     Case Studies     Company Profiles     Editor´s Picks Full Text Title

The Market Industry News Regulatory News General Health Legal/IPR News Product/R&D News API/Bulk Drug News People in the News Other News Top News Worldwide Editorials Commentaries Expert Opinions Interviews Case Studies Company Profiles Editor´s Picks

MNCs Must Rethink Their China Strategies as the Government Reveals Its Ironclad ... Chief Editor James Shen offers his monthly review of the Chinese healthcare sector with this issue's emphasis on growing uncertainties and threats facing MNCs as U.S.-Chi... (9/2/2019) Chinese Vitamin C Price-Fixing Case Could Alter U.S. Drug Market (9/9/2019) U.S. Expert Calls to Get Tough on Chinese Drug Manufacturers (9/6/2019) Next Up In China Trade War: Biotech Purge? (9/4/2019) China's Innovative Turn and the Changing Pharmaceutical Landscape (9/3/2019) MNCs Must Rethink Their China Strategies as the Government Reveals Its Ironclad Hand on Healthcare Economy (9/2/2019) Review of Chinese Pharma Deals, R&D and Regulatory Developments in H1/2019 (8/26/2019) China's Biopharma Strategy: Challenge or Complement to U.S. Industry Competitiveness? (8/21/2019) Cancer Treatment in China: The Underestimated Opportunity (8/21/2019) China's Central Government Introduces Major Policy Incentives and Restraints to the MedTech Industry (8/20/2019) How to Use China's 2019 Negative Lists (8/16/2019) China Has Become A CEO-Level Priority for MNC Cos: Trend and Implications (8/14/2019) Digital Must Deliver Both Speed and Depth (8/12/2019) Hospital Market and MNCs Rose Higher in Q1/2019 amid Growing Uncertainties and New Policies (8/8/2019) Pentagon Sees Security Threat in Chinese Drug-Supply Dominance (8/6/2019) Dealing with the Chinese Challenge: The Case of the Pharma Industry (8/2/2019) Biocon, CMS Enter Licensing Deal to Sell...  (9/15/2019) HK and Shanghai Star Listings to Boost E...  (9/15/2019) Recent Executive Moves  (9/15/2019) Janssen Granted Chinese Approval of Acte...  (9/12/2019) Upcoming Event: Dementia Conclave 2020  (9/12/2019) (free) Upcoming Event: 6th Annual European Phar...  (9/12/2019) (free) Upcoming Event: Pharma CI USA Conference...  (9/12/2019) (free) Upcoming Event: The 2nd Saudi Internatio...  (9/12/2019) (free) Upcoming Event: The 2nd Saudi Internatio...  (9/12/2019) (free) Upcoming Event: World NO Diabetes 2020  (9/11/2019) (free) Hansoh Atomwise Launch Strategic AI Drug...  (9/11/2019) Fosun Unit Henlius Aims to Raise $477M i...  (9/11/2019) China Announces Tariff Exemptions on U.S...  (9/11/2019) Athenex Announces Initiation of Phase I ...  (9/11/2019) NMPA Solicits Public Comments on Five St...  (9/11/2019) Pfizer to Absorb Mylan, Creating Global Generic Powerhou... PhRMA Calls for Trade Deals That Force Countries to Pay ... IQVIA: Global Pharma to Grow Slower in the Next Five Yea... Pfizer and GSK Announce JV to Create a Global Consumer H... Top 25 Global Pharmaceutical Companies by Market Cap 201... China Announces Tariff Exemptions on U.S Goods Including Antica... SMEI: Top Chemical Drug Products in Urban Chinese Retail Pharma... IQVIA: Overall Chinese Pharma Market Growth Slowed to 4.5% in 2... CitiResearch - China at Inflection Point: Big Opportunity for M... Sinohealth Projects Lower Chinese Pharmaceutical Market Growth ... Biocon, CMS Enter Licensing Deal to Sell Three Drugs in Chin... HK and Shanghai Star Listings to Boost Expansion of Chinese ... Janssen Granted Chinese Approval of Actelion’s Pediatric PA... Fosun Unit Henlius Aims to Raise $477M in Hong Kong IPO Taiho's Gastric Cancer Drug LONSURF (trifluridine/tipiracil)... NMPA Solicits Public Comments on Five Standards for Esse... CDE Seeks Comments on Draft Chinese Translations of ICH ... CDE Publicizes Three Drug Applications To Be Granted Pri... CPA Releases Announcement for Excessively-Supplied Drug ... House Dem Demands Sanctions on Chinese Pharma Cos for Ro... China Adopts New Amendment of PRC Drug Administration Law New Revision Draft of Drug Administration Law Submitted to t... Cancer Research Facilities Become A Target of Chinese Hacker... Healthcare-Related AI Patent Surge in China Reflects Momentu... China Moves Up in Global Innovation Ranking Novartis Disposes Suzhou Novartis PharmTech in Changshu ... FDA Warns Chinese API Producer Yino WuXi STA Shanghai & Changzhou Facilities Pass U.... China Accounted for 67% of India's Bulk Drug Imports in ... Athenex Voluntarily Suspends Production at Its Chongqing... Hansoh Atomwise Launch Strategic AI Drug Discovery Colla... Athenex Announces Initiation of Phase I Trial in China o... Xynomic Pharma Reports Encouraging Data on Lead Cancer D... AZ's Breztri COPD Candidate Aerosphere (PT010) Maybe App... USFDA Grants Priority Review to BeiGene's Zanubrutinib i... NHC Issues Clinical Guidelines for Ten Disease Groups WHO: China Has The World's Biggest Hepatitis C Problem Central government Issues New Document for National Esse... National Medical Insurance Research Institute Establishe... China's Expands 4+7 Trial to Almost the Entire Country Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves Upcoming Event: Dementia Conclave 2020 Upcoming Event: 6th Annual European Pharma Market Resear... Upcoming Event: Pharma CI USA Conference & Exhib... Upcoming Event: The 2nd Saudi International Pharma Expo Upcoming Event: The 2nd Saudi International Medlab Expo Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector... WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...   WiCON Publishes the China Phar...   WiCON to Hold Pharma China Ann...   WiCON Publishes the China Phar...   WiCON Officially Publishes Chi...   WiCON Officially Publishes Chi...

© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links